Search
for
Sort by
Research 121–150 of 1000+
- Migration Inhibitory Factor in Conditioned Medium from Human Umbilical Cord Blood-Derived Mesenchymal Stromal Cells Stimulates Hair Growth
- Frontal Fibrosing Alopecia: Update and Review of Challenges and Successes
- MANAGEMENT OF ENDOCRINE DISEASE Hyperandrogenic states in women: pitfalls in laboratory diagnosis
- Modulating testosterone pathway: a new strategy to tackle male skin aging?
- Botanicals With Dermatologic Properties Derived From First Nations Healing: Part 1—Trees
- Efficacy and Safety of Platelet-Rich Plasma in Melasma: A Systematic Review
- The use of phosphodiesterase inhibitors for the treatment of alopecia
- Outcome Measures in Cutaneous Autoimmune Disease: Dermatomyositis and Lupus Erythematosus
- Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review
- Modelling of the composition of emulsion medicines and cosmetics stabilized by a biocomplex of surfactant substances based on rhamnolipids Pseudomonas sp. PS-17
- Cicatricial Alopecia
- Biotin - facts and hopes
- Hypersensitivity Diseases
- Bridging psychoneuroimmunology and homeopathy: Modulating the cellular and emotional cascades in refractory alopecia
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Emerging Therapies for Acne Vulgaris
- Targets to treat androgen excess in polycystic ovary syndrome
- Mesenchymal Stem Cells and Stromal Vascular Fraction for Hair Loss
- Efficacy of Intralesional and Oral Dutasteride in the Treatment of Androgenetic Alopecia: A Systematic Review
- Green Tea Extract: A Novel Addition to the Antihirsutism Armamentarium?
- Radiotherapy-Induced Skin Fibrosis: Pathophysiology, Emerging Therapeutics, and the Role of Dermatology
- Cytostatics and immunosuppressive drugs
- Commentary
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- An Overview of Alopecias
- Treatment strategies for alopecia
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- Non-invasive Approaches for the Diagnosis of Autoimmune/Autoinflammatory Skin Diseases—A Focus on Psoriasis and Lupus erythematosus